North Dakota Bill Proposes Reclassification of Kratom

A new legislative proposal in North Dakota aims to reclassify kratom, a Southeast Asian herbal supplement, as a Schedule I controlled substance. House Bill 1101, introduced during the 69th Legislative Assembly, seeks to place kratom alongside substances like fentanyl, citing concerns over its potential for abuse and opioid-like effects.

Kratom, derived from the Mitragyna speciosa tree, has gained popularity in the U.S. for its reported benefits in managing pain and alleviating opioid withdrawal symptoms. However, critics argue that its unregulated availability and potential addictive properties pose risks. Advocates, including the American Kratom Association, oppose the bill, emphasizing regulation over prohibition to ensure consumer safety and access.

The bill has sparked debate over kratom’s role in public health, with ongoing studies by federal agencies exploring its potential as a tool in combating the opioid epidemic. For more details, visit Minot Daily News.